CRRFY(CRRFY)
CRRFY
No analyst ratings available
No analyst price targets available for CRRFY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $80.98B | $82.24B | $83.86B | $82.82B | $84.06B |
| Low | $80.17B | $81.43B | $83.03B | $82.00B | $83.22B |
| High | $81.96B | $83.24B | $84.88B | $83.83B | $85.08B |
| EBITDA Avg | $4.45B | $4.52B | $4.61B | $4.55B | $4.62B |
| Low | $4.41B | $4.48B | $4.56B | $4.51B | $4.57B |
| High | $4.50B | $4.57B | $4.66B | $4.61B | $4.68B |
| EBIT Avg | $2.15B | $2.18B | $2.22B | $2.20B | $2.23B |
| Low | $2.13B | $2.16B | $2.20B | $2.17B | $2.21B |
| High | $2.17B | $2.21B | $2.25B | $2.22B | $2.26B |
| Net Income Avg | $1.16B | $1.25B | $1.34B | $1.31B | $1.40B |
| Low | $1.13B | $1.18B | $1.32B | $1.29B | $1.38B |
| High | $1.18B | $1.31B | $1.36B | $1.33B | $1.42B |
| EPS Avg | $0.34 | $0.36 | $0.39 | $0.38 | $0.41 |
| Low | $0.33 | $0.35 | $0.39 | $0.38 | $0.40 |
| High | $0.34 | $0.38 | $0.40 | $0.39 | $0.42 |
| Analysts (Rev / EPS) | 5 / 2 | 5 / 2 | 1 / 1 | 2 / 1 | 2 / 1 |